Abstract:Layla Kamareddine, 1– 3 Crystal M Ghantous, 4 Soumaya Allouch, 5 Sarah A Al-Ashmar, 2, 5 Gulsen Anlar, 2, 5 Surya Kannan, 2, 5 Laiche Djouhri, 2, 5 Hesham M Korashy, 2, 6 Abdelali Agouni, 2, 6 Asad Zeidan 2, 5 1 Department Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar; 2 Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar; 3 Biomedical Research Center, Qatar University, Doha, Qatar; 4 Department of Nursing and Health Sciences, Faculty of Nursing and Health Sciences, Notre Dame University-Louaize, Keserwan, Lebanon; 5 Department of Basic Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar; 6 Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Doha, Qatar Correspondence: Asad Zeidan Department of Basic Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar Email Cardiac remodeling is the process by which the heart adapts to stressful stimuli, such as hypertension and ischemia/reperfusion; it ultimately leads to heart failure upon long-term exposure. Autophagy, a cellular catabolic process that was originally considered as a mechanism of cell death in response to detrimental stimuli, is thought to be one of the main mechanisms that controls cardiac remodeling and induces heart failure. Dysregulation of the adipokines leptin and adiponectin, which plays essential roles in lipid and glucose metabolism, and in the pathophysiology of the neuroendocrine and cardiovascular systems, has been shown to affect the autophagic response in the heart and to contribute to accelerate cardiac remodeling. The obesity-associated protein leptin is a pro-inflammatory, tumor-promoting adipocytokine whose elevated levels in obesity are associated with acute cardiovascular events, and obesity-related hypertension. Adiponectin exerts anti-inflammatory and anti-tumor effects, and its reduced levels in obesity correlate with the pathogenesis of obesity-associated cardiovascular diseases. Leptin- and adiponectin-induced changes in autophagic flux have been linked to cardiac remodeling and heart failure. In this review, we describe the different molecular mechanisms of hyperleptinemia- and hypoadiponectinemia-mediated pathogenesis of cardiac remodeling and the involvement of autophagy in this process. A better understanding of the roles of leptin, adiponectin, and autophagy in cardiac functions and remodeling, and the exact signal transduction pathways by which they contribute to cardiac diseases may well lead to discovery of new therapeutic agents for the treatment of cardiovascular remodeling. Keywords: inflammation, autophagy, leptin, adiponectin, cardiac cells The World Health Organization (WHO) classifies cardiovascular diseases as the leading cause of death worldwide, with an estimated 17.9 million annual deaths attributed to this class of diseases. 1 Risk factors of cardiac remodeling, hypertrophy, and heart failure are various; however, hypertension is a crucial player in the pathogenesis of these conditions. 2 Hypertension induces increased mechanical stretch of the vascular smooth muscle cells. 3 The ability of the cardiac muscle to sense and respond to mechanical stretch occurs through a process known as mechanotransduction, which is the conversion of mechanical triggers into biochemical incidents. 4 This, in turn, causes a change in myocardial function and structure as a compensatory mechanism during adaptation to the trigger. 5 In the case of prolonged stimuli, signal transduction occurs and the whole process becomes maladaptive, causing a change in the physiology of the heart, and subsequently leading to development of cardiac remodeling/hypertrophy. 5,6 Leptin and adiponectin are physiologically essential for glucose and lipid metabolism, as well as neuroendocrine and cardiovascular functions. However, at dysregulated levels, they are considered major contributors to the pathogenesis of heart failure. 7 The biological characteristics of the aforementioned adipokines are contradictory. Explicitly, adiponectin triggers potent anti-inflammatory and anti-tumor responses as opposed to the pro-inflammatory and tumor-promoting features of leptin. 8 Although the effects of adiponectin and leptin on cardiac remodeling are multifactorial in nature, recent studies have reported that they take place through the induction of autophagy. 8 Autophagy, a cellular catabolic process, was originally considered a mechanism of cell death in response to detrimental s -Abstract Truncated-

Autophagy Inhibition Rescues Against Leptin-Induced Cardiac Contractile Dysfunction

Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway.

Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling

High-Fat Diet-Induced Obesity Leads To Resistance To Leptin-Induced Cardiomyocyte Contractile Response

Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO.

Molecular and Cellular Mechanisms Underlying the Cardiac Hypertrophic and Pro-Remodelling Effects of Leptin

Leptin Modifies the Rat Heart Performance Associated with Mitochondrial Dysfunction Independently of Its Prohypertrophic Effects

Central Actions of Leptin Induce an Atrophic Pattern and Improves Heart Function in Lean Normoleptinemic Rats via PPARβ/δ Activation

Epicardial Adipose Tissue-Derived Leptin Promotes Myocardial Injury in Metabolic Syndrome Rats Through PKC/NADPH Oxidase/ROS Pathway

Impaired cardiac function in leptin-deficient mice

Impaired Cardiac Contractile Function In Ventricular Myocytes From Leptin-Deficient Ob/Ob Obese Mice

Between Inflammation and Autophagy: The Role of Leptin-Adiponectin Axis in Cardiac Remodeling

Increased Leptin by Hypoxic-Preconditioning Promotes Autophagy of Mesenchymal Stem Cells and Protects Them from Apoptosis

Antioxidant Catalase Rescues Against High Fat Diet-Induced Cardiac Dysfunction Via an IKKβ-AMPK-dependent Regulation of Autophagy.

Insulin Resistance Induces Hyperleptinemia, Cardiac Contractile Dysfunction but Not Cardiac Leptin Resistance in Ventricular Myocytes

Inhibition of Ampk Accentuates Prolonged Caloric Restriction-Induced Change in Cardiac Contractile Function Through Disruption of Compensatory Autophagy

Leptin Protects Cardiomyocytes from Serum-Deprivation-Induced Apoptosis by Increasing Anti-Oxidant Defence

Abstract 15517: Deficiency of AMPK Exacerbates Lipopolysaccharide-Induced Cardiac Contractile Dysfunction: the Role of Autophagy

Abstract 486: Genetic Deletion of Akt2 and AMPK Accentuates Insulin Resistance-Induced Cardiac Contractile Anomalies

Interaction between tumor necrosis factor-alpha and leptin-induced inhibition of cardiac contractile function in isolated ventricular myocytes.

Deletion of Protein Tyrosine Phosphatase 1B Rescues Against Myocardial Anomalies in High Fat Diet-Induced Obesity: Role of AMPK-dependent Autophagy.